Ethex recalls three lots of dextroamphetamine tablets
This article was originally published in Scrip
Executive Summary
KV Pharmaceutical's Ethex generics division has recalled three lots of dextroamphetamine 5mg tablets owing to the possible presence of oversized tablets which may contain twice the labelled amount of active ingredient. The recalled lots were distributed under the Ethex label between January 2007 and May 2008. The company said it found a small number of oversized tablets in lots that had not yet been distributed. There have been no reports from wholesalers, retailers or consumers about oversized tablets and no reports of unexpected side effects or injuries.